ATE106886T1 - Azabicycloamide und -ester als 5-ht3-receptor- antagonisten. - Google Patents

Azabicycloamide und -ester als 5-ht3-receptor- antagonisten.

Info

Publication number
ATE106886T1
ATE106886T1 AT90312218T AT90312218T ATE106886T1 AT E106886 T1 ATE106886 T1 AT E106886T1 AT 90312218 T AT90312218 T AT 90312218T AT 90312218 T AT90312218 T AT 90312218T AT E106886 T1 ATE106886 T1 AT E106886T1
Authority
AT
Austria
Prior art keywords
esters
azabicycloamides
receptor antagonists
antagonists
receptor
Prior art date
Application number
AT90312218T
Other languages
English (en)
Inventor
Terry Jay Rosen
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE106886T1 publication Critical patent/ATE106886T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT90312218T 1989-11-17 1990-11-08 Azabicycloamide und -ester als 5-ht3-receptor- antagonisten. ATE106886T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1989/005097 WO1991007402A1 (en) 1989-11-17 1989-11-17 Azabicyclo amides and esters as 5-ht3 receptor antagonists

Publications (1)

Publication Number Publication Date
ATE106886T1 true ATE106886T1 (de) 1994-06-15

Family

ID=22215354

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90312218T ATE106886T1 (de) 1989-11-17 1990-11-08 Azabicycloamide und -ester als 5-ht3-receptor- antagonisten.

Country Status (11)

Country Link
EP (1) EP0434202B1 (de)
JP (1) JPH0699428B2 (de)
AT (1) ATE106886T1 (de)
CA (1) CA2030077C (de)
DE (1) DE69009715T2 (de)
DK (1) DK0434202T3 (de)
ES (1) ES2055344T3 (de)
FI (1) FI922124A (de)
IE (1) IE63420B1 (de)
PT (1) PT95895A (de)
WO (1) WO1991007402A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9027111D0 (en) * 1990-12-13 1991-02-06 Raychem Ltd Circuit protection device
GB9214184D0 (en) * 1992-07-03 1992-08-12 Smithkline Beecham Plc Pharmaceuticals
FR2699533A1 (fr) * 1992-12-21 1994-06-24 Mouhtaram Mohamed Dérivés de N-((1,4-dialkyl-6-arylpipérazine-2-yl)méthyl)benzamides. (Isomères cis et trans) Propriétés pharmacologiques et applications.
AU2005319248A1 (en) * 2004-12-22 2006-06-29 Memory Pharmaceuticals Corporation Nicotinic alpha-7 receptor ligands and preparation and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3405134A (en) * 1965-08-17 1968-10-08 Colgate Palmolive Co Quinuclidyl esters of aromatic acids
US4467095A (en) * 1969-02-10 1984-08-21 Fmc Corporation Anticholinergic compounds
US3563995A (en) * 1969-04-17 1971-02-16 Ian Wellings Alkyl esters of 1-azabicyclo(2.2.2)oct-2-ene-3-(4 - chloro-3-sulfamoylanilino)-2-carboxylic acid
GB1293446A (en) * 1970-07-23 1972-10-18 Rech S Et D Applic Scient Soge Quinuclidine derivatives, the preparation thereof and pharmaceutical compositions containing them
FR2531955A1 (fr) * 1982-08-17 1984-02-24 Pharmuka Lab Nouveau procede de preparation de derives de la quinuclidine substitues en position 3
CH667657A5 (de) * 1985-01-07 1988-10-31 Sandoz Ag Carbocyclische und heterocyclische carbonylmethylen- und methylpiperidine und -pyrrolidine.
GB8525844D0 (en) * 1985-10-19 1985-11-20 Beecham Group Plc Compounds
EP0311724A1 (de) * 1987-10-16 1989-04-19 Synthelabo Anxiolytische R-N-(1-Azabicyclo[2.2.2]oct-3-yl)-benzamide und -thiobenzamide

Also Published As

Publication number Publication date
IE63420B1 (en) 1995-04-19
DE69009715T2 (de) 1994-09-22
FI922124A0 (fi) 1992-05-11
PT95895A (pt) 1991-09-13
WO1991007402A1 (en) 1991-05-30
DK0434202T3 (da) 1994-07-04
FI922124A (fi) 1992-05-11
CA2030077A1 (en) 1991-05-18
EP0434202A1 (de) 1991-06-26
IE904134A1 (en) 1991-05-22
JPH03170480A (ja) 1991-07-24
EP0434202B1 (de) 1994-06-08
DE69009715D1 (de) 1994-07-14
JPH0699428B2 (ja) 1994-12-07
ES2055344T3 (es) 1994-08-16
CA2030077C (en) 1995-08-22

Similar Documents

Publication Publication Date Title
DE69127791T2 (de) Diazabicyclononyl-Derivate als 5-HT3 Rezeptor Antagonisten
SE8303651L (sv) Bensoesyrapiperidylesterderivat
FI921345A (fi) Piperidinderivat
FI964004A0 (fi) Serotoniiniantagonistien (5HT3) käyttö fibromyalgian hoitoon
DE3476204D1 (de) N-(bicyclic heterocyclyl)-4-piperidinamines
DE69207351D1 (de) Fibrinogen-Rezeptor-Antagoniste
DE69431604D1 (de) Benzofuranderivate als tachykininantagonisten
NO844755L (no) Bicykliske heterocyklyholdige n-(bicykliske heterocyklyl)-4-piperidinaminer
DE69425655T2 (de) Antagonisten des fibrinogenrezeptors
DE69012867T2 (de) Direktanlernbarer Roboter.
DE69022553T2 (de) Vorrichtung zum Unterdrücken von Spannungsschwankungen und Oberschwingungen.
DE69426452D1 (de) Fibrinogen receptor antagonisten
FI945000A0 (fi) Menetelmä (S)-amino-1-substituoitujen pyrrolidiinien valmistamiseksi
DE69009715D1 (de) Azabicycloamide und -ester als 5-HT3-Receptor-Antagonisten.
FR2625678B1 (fr) Agents anorexigenes a base de n-(quinuclidin-3-yl)-benzamides ou thiobenzamides
FI891473A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 4-aryyli-4-piperidiinikarbinolien valmistamiseksi
DE69328701T2 (de) Diazabicycloderivate als 5-HT3-Antagonisten
FI913835A0 (fi) 6-substituerade-tetrahydrobenz(cd) indoler.
FI892051A (fi) Foerfarande foer framstaellning av 5-klor-3-klorsulfonyl-2-tiofencarbonsyraestrar.
DE69023747T3 (de) Verwendung von Aminoxiden als antistatischen Agenzien.
IT9083326A0 (it) Attrezzo per sviluppare le capacita' psico-motorie del bambino
LV10425A (lv) Fibrinogena receptoru antagonisti
KR950004751U (ko) 모니터의 화면 마아킹 치구
IE881220L (en) 5-ht3 receptor antagonists
DE69308680D1 (de) Gebrauch von Oxatomide als Antitussivum